Literature DB >> 15203281

Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.

Radovan Borojevic1, Rosimeire A Roela, Renato S Rodarte, Leandro S Thiago, Fátima S Pasini, Fabiana M Conti, Maria Isabel D Rossi, Luiz F L Reis, Luiz F Lopes, M Mitzi Brentani.   

Abstract

We studied bone marrow stromal cell cultures from patients with childhood myelodysplastic syndromes (MDS, refractory anemia with excess of blasts, RAEB) and from matched normal donors. Stromal cell monolayers were characterized as myofibroblasts by the expression of smooth muscle alpha-actin, collagen IV, laminin and fibronectin. When normal cord blood cells were plated onto myelodysplastic stromas, a pathologic cell differentiation was observed, indicating altered myelosupportive properties. cDNA array analysis showed that patient stromas expressed increased levels of thrombospondin-1, collagen-I alpha2-chain, osteoblast-specific factor-2 and osteonectin, indicating the presence of increased osteoblast content, as confirmed by enhanced alkaline phosphatase synthesis. Alterations in the myelodysplastic stroma environment might contribute to abnormal hematopoiesis in this pathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203281     DOI: 10.1016/j.leukres.2003.11.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 2.  Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.

Authors:  Joseph Lasky; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-03-14

3.  Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.

Authors:  Olga Blau; Claudia Dorothea Baldus; Wolf-Karsten Hofmann; Gundula Thiel; Florian Nolte; Thomas Burmeister; Seval Türkmen; Ouidad Benlasfer; Elke Schümann; Annette Sindram; Mara Molkentin; Stefan Mundlos; Ulrich Keilholz; Eckhard Thiel; Igor Wolfgang Blau
Journal:  Blood       Date:  2011-09-23       Impact factor: 22.113

4.  Myeloid malignancies and the microenvironment.

Authors:  Claudia Korn; Simón Méndez-Ferrer
Journal:  Blood       Date:  2016-11-15       Impact factor: 22.113

Review 5.  Normal and leukemic stem cell niches: insights and therapeutic opportunities.

Authors:  Koen Schepers; Timothy B Campbell; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

6.  Establishment of a xenograft model of human myelodysplastic syndromes.

Authors:  Yukari Muguruma; Hiromichi Matsushita; Takashi Yahata; Shizu Yumino; Yumiko Tanaka; Hayato Miyachi; Yoshiaki Ogawa; Hiroshi Kawada; Mamoru Ito; Kiyoshi Ando
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

7.  Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.

Authors:  Gergely Varga; Judit Kiss; Judit Várkonyi; Virág Vas; Péter Farkas; Katalin Pálóczi; Ferenc Uher
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

8.  Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.

Authors:  A B M Madureira; M Eapen; F Locatelli; P Teira; M-J Zhang; S M Davies; A Picardi; A Woolfrey; K-W Chan; G Socié; A Vora; Y Bertrand; C M Sales-Bonfim; E Gluckman; C Niemeyer; V Rocha
Journal:  Leukemia       Date:  2010-12-07       Impact factor: 11.528

9.  Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.

Authors:  Miyoung Kim; Seungwoo Hwang; Kiejung Park; Seon Young Kim; Young Kyung Lee; Dong Soon Lee
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.

Authors:  J C Huang; S K Basu; X Zhao; S Chien; M Fang; V G Oehler; F R Appelbaum; P S Becker
Journal:  Blood Cancer J       Date:  2015-04-10       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.